Most people with COVID-19 are contagious for about 8 to 10 days total, starting 1 to 2 days before symptoms appear. Peak infectiousness hits right around symptom onset and during the first five days of illness. After that, the risk of spreading the virus drops sharply, though some people remain infectious a bit longer.
The Standard Contagious Window
The contagious period begins before you even know you’re sick. You can start spreading the virus 1 to 2 days before your first symptom, which is one reason COVID spreads so efficiently. From there, viral levels climb quickly and peak around the time symptoms start.
Transmission risk is highest at or near symptom onset and during the first five days of illness. In mild cases, viral load typically persists for 7 to 10 days after symptoms begin, but the amount of live, replicable virus drops well before that. By around day 10, studies consistently find that while PCR tests may still detect viral genetic material, researchers can no longer grow live virus from swab samples. That distinction matters: detectable viral RNA does not mean you’re still infectious.
Why a Positive Test Doesn’t Always Mean Contagious
PCR tests are extremely sensitive. They pick up fragments of viral RNA that can linger for weeks after you’ve stopped being a transmission risk. This is why many people test positive on a PCR long after they’ve recovered, which can be confusing and stressful.
Rapid antigen tests, on the other hand, are a much better indicator of whether you’re actually contagious. A study comparing antigen test results to viral cultures (the gold standard for determining if live virus is present) found that a negative rapid antigen test had a 99% negative predictive value for contagiousness. In other words, if your rapid test is negative, the odds that you’re still carrying enough live virus to infect someone are extremely low. On the flip side, 96% of samples that grew live virus in the lab also tested positive on a rapid antigen test. If you’re trying to figure out whether it’s safe to be around others, a rapid test is your most practical tool.
Vaccinated vs. Unvaccinated Timelines
Vaccination shortens the contagious window. Research on the Delta variant found that vaccinated people cleared the virus faster than unvaccinated people. With the Omicron variant, vaccinated individuals with mild or no symptoms shed infectious virus for roughly 6 to 9 days after symptom onset or diagnosis, even after symptoms had resolved. That’s on the shorter end of the overall range, but it’s a reminder that feeling better doesn’t automatically mean you’ve stopped being contagious.
If You Never Develop Symptoms
People who stay asymptomatic throughout their infection still carry and shed the virus, but their contagious window appears to follow a similar or slightly shorter timeline compared to symptomatic cases. The practical challenge is that without symptoms to mark a starting point, it’s harder to know where you are in the timeline. This is another situation where rapid antigen testing is especially useful for gauging your current risk to others.
Immunocompromised People Can Be Contagious Much Longer
For people with weakened immune systems, the contagious period can extend dramatically. A systematic review found that among immunocompromised patients, the median duration of live, replicable virus was about 60 days from symptom onset. The longest documented case involved a person with untreated HIV who shed live virus for 268 days, nearly nine months, from their first positive test.
These are not typical cases, but they’re important context for anyone with a condition that suppresses immune function, such as organ transplant recipients on anti-rejection drugs, people undergoing chemotherapy, or those with untreated HIV. If you fall into one of these categories, your infectious period may extend well beyond the standard 10-day window, and testing to confirm clearance becomes especially important.
COVID Rebound After Antiviral Treatment
Some people who take antiviral medication experience a rebound, where symptoms return and viral levels spike again after an initial improvement. This rebound can happen whether or not you’ve taken antivirals, though it drew widespread attention in connection with antiviral treatment. During a rebound, you should treat yourself as contagious again. The CDC recommends following the same isolation guidance you would during an initial infection, including masking around others.
Current CDC Guidance on Returning to Normal
As of 2024, the CDC simplified its respiratory virus recommendations. Rather than a fixed number of isolation days, the guidance now ties your return to normal activities to two conditions: your symptoms have been improving overall for at least 24 hours, and any fever has been gone for at least 24 hours without fever-reducing medication.
Once you meet those criteria and resume daily life, the CDC encourages five additional days of precautions. That means wearing a well-fitting mask around others, improving ventilation when indoors, keeping some distance when possible, and practicing good hand hygiene. This layered approach acknowledges that some people are still shedding virus even after they feel better, while avoiding the rigidity of a one-size-fits-all isolation period.
Practical Takeaways for Timing
If you’re trying to protect the people around you, here’s how these numbers translate into real decisions. Your highest-risk days are the day before symptoms start through about day five. After that, risk drops but doesn’t vanish immediately. Most people with normal immune function stop being contagious somewhere between days 8 and 10.
A negative rapid antigen test is the single most reliable signal that you’re no longer a meaningful transmission risk. If you’re still testing positive on a rapid test, you’re likely still shedding enough live virus to infect others, regardless of how you feel. Two negative rapid tests taken 48 hours apart give you even more confidence. For immunocompromised individuals, testing remains essential because the standard timelines simply don’t apply.